Skip to main content
. 2015 Dec 18;7(4):4972–4980. doi: 10.18632/oncotarget.6649

Table 3. Diagnostic performance of mir-bart1-5p and other current methods.

COV Sensitivity (%) Specificity (%) PPV (%) NPV (%)
mir-bart1-5p 0.050 93.5 100 100 93.7
Initial biopsy N/A 92.6 100 100 92.9
VCA-IgA ≥ 1:80 80.9 85.6 85.3 81.3
EA-IgA ≥ 1:10 68.8 92.8 91.4 74.4